Real-world Evidence of Self-reported Treatments, Signs, and Symptom Burden in Chronic Hand Eczema: Findings from the Multinational CHECK Study. [PDF]
Molin S +9 more
europepmc +1 more source
ABSTRACT Atopic dermatitis (AD) is a chronic, itchy skin disease that often begins in infancy and may persist into adulthood. The high co‐occurrence of allergic comorbidities (ACMs; asthma, food allergy, and allergic rhinitis) makes it a growing public health concern.
Masaki Futamura +6 more
wiley +1 more source
Newborn technology use in low-resource settings: the role of health professionals' communication in implementation. [PDF]
Ngaiza GK +5 more
europepmc +1 more source
Colostrum as a Protective Factor Against Peanut Allergy: Evidence From a Birth Cohort
This study investigates whether partial colostrum feeding (PCF) due to formula supplements in the first 3 days increases the risk of food allergy beyond cow's milk. PCF infants showed increased risk of peanut allergy and multiple food allergies compared to exclusively colostrum‐fed (ECF) infants.
Maheshwar Bhasin +11 more
wiley +1 more source
Neonatal Hyperbilirubinemia in Uganda: Mechanisms, Clinical Consequences, and Health-System Challenges. [PDF]
Hamdi MY +9 more
europepmc +1 more source
Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions
ABSTRACT Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases worldwide. The clinical presentation of AD is heterogeneous and is characterized by a relapsing and remitting course. Most patients suffer from mild AD while approximately 5% to 20% experience severe disease activity, which often requires systemic treatment ...
Marjolein S. de Bruin‐Weller +9 more
wiley +1 more source
The efficacy of topical calcineurin inhibitor therapy for childhood vitiligo: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies. [PDF]
Jiang T, Wu W.
europepmc +1 more source
Clinical and Molecular Effect of the Anti–IL‐18 Antibody Aletekitug in Adults With Atopic Dermatitis
At Week 12, aletekitug was associated with a −68.3% percentage change from baseline in EASI score. Aletekitug improved the transcriptional profile of lesional skin towards that of non‐lesional skin at Week 4 and Week 12. Aletekitug was well‐tolerated; no serious adverse event or death occurred, and no patient withdrew due to an adverse event.
Joanne Ellis +32 more
wiley +1 more source
The prediction of phototherapy by early postnatal ETCOc in Chinese newborns. [PDF]
Yang G +18 more
europepmc +1 more source
Addressing complexity in the study of life sciences through Systems Biology and Systems Medicine has been transformative, making Systems Pharmacology the next logical step. In this review, we focus on physical stimuli, whose potential in pharmacology has been neglected, despite demonstrated therapeutic properties.
Veronica Paparozzi +10 more
wiley +1 more source

